Biogen of US might reap W2tr from Samsung Bioepis call option
Samsung Biologics Prepares for Budding Alzheimer's Treatment Deals
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
Samsung buys Biogen out of biosimilar unit for $2.3B—not the whole Aduhelm headache | Fierce Pharma
Company News | Newsroom | SAMSUNG BIOLOGICS
Biosimilaires : Samsung Bioepis conclut un nouvel accord de commercialisation avec Biogen | MyPharma Editions
Samsung Bioepis looks to acquire Biogen's biosim unit: reports
Samsung intéressé par le rachat du laboratoire Biogen | La Presse
Logo De Société De Biotechnologie De Biogen Image éditorial - Image du médecines, hématologique: 102563960
Samsung in talks to acquire Biogen, per report - The Boston Globe
Biogen and Samsung land FDA approval for biosimilar to blockbuster Roche drug - MedCity News
Biogen gains ophthalmology biosimilar candidates for Lucentis, Eylea in deal with Samsung Bioepis
Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million | BioSpace
Samsung Bioepis ponders acquiring unit from U.S. partner Biogen
Biogen Recoups Much-Needed $2.3B with Sale of Samsung Bioepis Stake | BioSpace
Biogen and Samsung Bioepis present data for Infliximab and Adalimumab biosimilars - Hub Publishing
Samsung Bioepis conclut un nouvel accord de commercialisation avec Biogen
Samsung intéressé par le rachat du laboratoire Biogen pour plus de $40 milliards | Arab News FR
Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn
Samsung Bioepis considering takeover of Biogen's unit: reports
Samsung Biologics buys out Biogen in biosim venture for US$2.3B | HealthCare Middle East & Africa Magazine
Samsung Biologics to acquire Biogen's stake in Samsung Bioepis
Samsung in Talks to Buy Alzheimer's Drug Maker Biogen for $42 Billion: Report | Technology News
Is Samsung really 'at negotiating table' for Biogen? What we know so far - MM+M
Biogen shares jump higher on report of potential Samsung acquisition
Biosimilaires : Biogen se déleste de Samsung Bioepis
Biogen, Samsung Bioepis Enter New Biosimilars Transaction | Contract Pharma
Samsung Bioepis seeks to buy Biogen biosimilar unit - KED Global
